Skip to content
Day One Biopharmaceuticals Inc icon

Day One Biopharmaceuticals Inc

DAWNStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$21.51

Today

-0.1%

YTD

+131.3%

About

Day One Biopharmaceuticals Inc is known for its work in the domain of precision medicine for children and adults suffering from cancer. It operates on a global scale. Serving the biotechnological and pharmaceutical industries, Day One Biopharmaceuticals Inc aims to provide specifically targeted and personalised treatments. The company partners with leading clinical oncologists, families and scientists to develop new cancer treatments. Its lead product candidate is Tovorafenib, a type 2 pan-RAF kinase inhibitor. Monitor the DAWN share price by adding it to your eToro watchlist.

Price chart
Closing price history for DAWN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-20.66
P/S (TTM)14.02
P/B (TTM)5.03
Market cap$2.22B
Cap tierMid-cap
Industry avg P/E-17.91

Profitability

Gross margin89.12%
EBIT margin-80.76%
Net margin-39.61%
ROE-22.74%
ROA-19.68%

Earnings & Revenue

Revenue (TTM)$158.18M
Revenue growth (1Y)+20.6%
EPS (TTM)-$1.04
Free cash flow$-104.08M
Total debt$2.79M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.96
Employees178
Next earnings5 May '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.